Zinc in PDB 4h1s: Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity
Enzymatic activity of Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity
All present enzymatic activity of Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity:
3.1.3.5;
Protein crystallography data
The structure of Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity, PDB code: 4h1s
was solved by
D.P.Heuts,
M.J.Weissenborn,
R.V.Olkhov,
A.M.Shaw,
C.W.Levy,
N.S.Scrutton,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
29.86 /
2.20
|
Space group
|
P 2 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
54.910,
95.010,
230.290,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
17.5 /
21.7
|
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity
(pdb code 4h1s). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity, PDB code: 4h1s:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 4h1s
Go back to
Zinc Binding Sites List in 4h1s
Zinc binding site 1 out
of 4 in the Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn602
b:9.8
occ:1.00
|
O1
|
A:PO4604
|
2.1
|
7.4
|
1.0
|
NE2
|
A:HIS220
|
2.1
|
7.0
|
1.0
|
ND1
|
A:HIS243
|
2.2
|
8.4
|
1.0
|
OD1
|
A:ASN117
|
2.3
|
5.9
|
1.0
|
OD2
|
A:ASP85
|
2.3
|
9.8
|
1.0
|
O
|
A:HOH1000
|
2.4
|
9.5
|
1.0
|
CE1
|
A:HIS243
|
2.9
|
8.4
|
1.0
|
CD2
|
A:HIS220
|
3.1
|
6.4
|
1.0
|
CE1
|
A:HIS220
|
3.1
|
8.8
|
1.0
|
CG
|
A:ASN117
|
3.2
|
8.6
|
1.0
|
CG
|
A:ASP85
|
3.3
|
10.6
|
1.0
|
P
|
A:PO4604
|
3.3
|
10.7
|
1.0
|
ZN
|
A:ZN603
|
3.4
|
15.9
|
1.0
|
CG
|
A:HIS243
|
3.4
|
10.9
|
1.0
|
ND2
|
A:ASN117
|
3.5
|
8.1
|
1.0
|
OD1
|
A:ASP85
|
3.7
|
10.0
|
1.0
|
O4
|
A:PO4604
|
3.7
|
8.1
|
1.0
|
O3
|
A:PO4604
|
3.8
|
10.8
|
1.0
|
CA
|
A:HIS243
|
3.8
|
10.0
|
1.0
|
OD2
|
A:ASP36
|
3.9
|
10.0
|
1.0
|
CB
|
A:HIS243
|
3.9
|
7.5
|
1.0
|
NE2
|
A:HIS243
|
4.1
|
8.4
|
1.0
|
CG
|
A:HIS220
|
4.2
|
9.1
|
1.0
|
ND1
|
A:HIS220
|
4.2
|
9.6
|
1.0
|
CD2
|
A:HIS118
|
4.2
|
9.2
|
1.0
|
O
|
A:HIS243
|
4.3
|
9.9
|
1.0
|
CD2
|
A:HIS243
|
4.4
|
9.5
|
1.0
|
CB
|
A:ASP85
|
4.5
|
6.5
|
1.0
|
O2
|
A:PO4604
|
4.5
|
11.7
|
1.0
|
C
|
A:HIS243
|
4.6
|
8.7
|
1.0
|
N
|
A:ASN117
|
4.6
|
6.7
|
1.0
|
CB
|
A:ASN117
|
4.6
|
9.1
|
1.0
|
N
|
A:HIS243
|
4.8
|
8.3
|
1.0
|
NE2
|
A:HIS118
|
4.9
|
9.7
|
1.0
|
O
|
A:HOH788
|
4.9
|
12.4
|
1.0
|
|
Zinc binding site 2 out
of 4 in 4h1s
Go back to
Zinc Binding Sites List in 4h1s
Zinc binding site 2 out
of 4 in the Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn603
b:15.9
occ:1.00
|
O
|
A:HOH1000
|
2.0
|
9.5
|
1.0
|
OD2
|
A:ASP36
|
2.1
|
10.0
|
1.0
|
O4
|
A:PO4604
|
2.1
|
8.1
|
1.0
|
NE2
|
A:HIS38
|
2.2
|
6.9
|
1.0
|
O
|
A:HOH973
|
2.2
|
5.4
|
1.0
|
OD2
|
A:ASP85
|
2.2
|
9.8
|
1.0
|
CE1
|
A:HIS38
|
3.1
|
7.2
|
1.0
|
CG
|
A:ASP85
|
3.2
|
10.6
|
1.0
|
CD2
|
A:HIS38
|
3.2
|
7.0
|
1.0
|
CG
|
A:ASP36
|
3.2
|
8.9
|
1.0
|
P
|
A:PO4604
|
3.2
|
10.7
|
1.0
|
ZN
|
A:ZN602
|
3.4
|
9.8
|
1.0
|
O1
|
A:PO4604
|
3.4
|
7.4
|
1.0
|
CB
|
A:ASP85
|
3.5
|
6.5
|
1.0
|
CB
|
A:ASP36
|
3.8
|
4.8
|
1.0
|
O
|
A:HOH778
|
3.8
|
9.2
|
1.0
|
O3
|
A:PO4604
|
3.9
|
10.8
|
1.0
|
NH2
|
A:ARG395
|
4.1
|
8.4
|
1.0
|
OD1
|
A:ASN245
|
4.2
|
7.0
|
1.0
|
CD2
|
A:HIS118
|
4.2
|
9.2
|
1.0
|
CE1
|
A:HIS220
|
4.2
|
8.8
|
1.0
|
NE2
|
A:HIS220
|
4.2
|
7.0
|
1.0
|
OD1
|
A:ASP36
|
4.3
|
7.4
|
1.0
|
ND1
|
A:HIS38
|
4.3
|
6.0
|
1.0
|
OD1
|
A:ASP85
|
4.3
|
10.0
|
1.0
|
CG
|
A:HIS38
|
4.3
|
7.2
|
1.0
|
O2
|
A:PO4604
|
4.5
|
11.7
|
1.0
|
CA
|
A:ASP36
|
4.5
|
7.1
|
1.0
|
O
|
A:HIS243
|
4.6
|
9.9
|
1.0
|
NE2
|
A:HIS118
|
4.8
|
9.7
|
1.0
|
CA
|
A:HIS243
|
4.8
|
10.0
|
1.0
|
CA
|
A:ASP85
|
5.0
|
7.0
|
1.0
|
|
Zinc binding site 3 out
of 4 in 4h1s
Go back to
Zinc Binding Sites List in 4h1s
Zinc binding site 3 out
of 4 in the Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn602
b:9.1
occ:1.00
|
O2
|
B:PO4604
|
2.1
|
5.9
|
1.0
|
NE2
|
B:HIS220
|
2.2
|
6.0
|
1.0
|
ND1
|
B:HIS243
|
2.3
|
6.8
|
1.0
|
OD1
|
B:ASN117
|
2.3
|
6.2
|
1.0
|
OD2
|
B:ASP85
|
2.3
|
8.4
|
1.0
|
O
|
B:HOH969
|
2.4
|
6.5
|
1.0
|
CE1
|
B:HIS243
|
3.1
|
9.8
|
1.0
|
CD2
|
B:HIS220
|
3.1
|
6.0
|
1.0
|
CE1
|
B:HIS220
|
3.2
|
6.9
|
1.0
|
CG
|
B:ASN117
|
3.2
|
9.1
|
1.0
|
CG
|
B:ASP85
|
3.2
|
8.7
|
1.0
|
P
|
B:PO4604
|
3.3
|
11.8
|
1.0
|
ZN
|
B:ZN603
|
3.4
|
16.7
|
1.0
|
CG
|
B:HIS243
|
3.4
|
9.1
|
1.0
|
ND2
|
B:ASN117
|
3.5
|
7.4
|
1.0
|
OD1
|
B:ASP85
|
3.6
|
6.8
|
1.0
|
O1
|
B:PO4604
|
3.7
|
8.6
|
1.0
|
O3
|
B:PO4604
|
3.8
|
8.9
|
1.0
|
CA
|
B:HIS243
|
3.8
|
7.0
|
1.0
|
CB
|
B:HIS243
|
3.8
|
7.5
|
1.0
|
OD1
|
B:ASP36
|
3.9
|
11.7
|
1.0
|
CD2
|
B:HIS118
|
4.2
|
9.2
|
1.0
|
NE2
|
B:HIS243
|
4.3
|
10.0
|
1.0
|
CG
|
B:HIS220
|
4.3
|
9.1
|
1.0
|
ND1
|
B:HIS220
|
4.3
|
6.7
|
1.0
|
O
|
B:HIS243
|
4.3
|
9.6
|
1.0
|
CD2
|
B:HIS243
|
4.4
|
9.3
|
1.0
|
CB
|
B:ASP85
|
4.5
|
6.6
|
1.0
|
O4
|
B:PO4604
|
4.5
|
10.2
|
1.0
|
C
|
B:HIS243
|
4.6
|
9.5
|
1.0
|
CB
|
B:ASN117
|
4.6
|
8.1
|
1.0
|
N
|
B:ASN117
|
4.6
|
7.8
|
1.0
|
N
|
B:HIS243
|
4.8
|
8.4
|
1.0
|
NE2
|
B:HIS118
|
4.8
|
10.2
|
1.0
|
O
|
B:HOH894
|
4.9
|
10.9
|
1.0
|
|
Zinc binding site 4 out
of 4 in 4h1s
Go back to
Zinc Binding Sites List in 4h1s
Zinc binding site 4 out
of 4 in the Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of A Truncated Soluble Form of Human CD73 with Ecto- 5'-Nucleotidase Activity within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn603
b:16.7
occ:1.00
|
O
|
B:HOH969
|
2.1
|
6.5
|
1.0
|
OD1
|
B:ASP36
|
2.1
|
11.7
|
1.0
|
OD2
|
B:ASP85
|
2.2
|
8.4
|
1.0
|
NE2
|
B:HIS38
|
2.2
|
10.0
|
1.0
|
O1
|
B:PO4604
|
2.2
|
8.6
|
1.0
|
O
|
B:HOH970
|
2.3
|
7.6
|
1.0
|
CG
|
B:ASP85
|
3.1
|
8.7
|
1.0
|
CE1
|
B:HIS38
|
3.2
|
9.1
|
1.0
|
CG
|
B:ASP36
|
3.2
|
9.1
|
1.0
|
CD2
|
B:HIS38
|
3.2
|
7.4
|
1.0
|
P
|
B:PO4604
|
3.3
|
11.8
|
1.0
|
ZN
|
B:ZN602
|
3.4
|
9.1
|
1.0
|
CB
|
B:ASP85
|
3.4
|
6.6
|
1.0
|
O2
|
B:PO4604
|
3.6
|
5.9
|
1.0
|
CB
|
B:ASP36
|
3.7
|
7.5
|
1.0
|
O3
|
B:PO4604
|
3.8
|
8.9
|
1.0
|
O
|
B:HOH758
|
3.9
|
10.1
|
1.0
|
NH2
|
B:ARG395
|
4.1
|
11.0
|
1.0
|
CD2
|
B:HIS118
|
4.2
|
9.2
|
1.0
|
OD2
|
B:ASP36
|
4.2
|
8.0
|
1.0
|
CE1
|
B:HIS220
|
4.2
|
6.9
|
1.0
|
OD1
|
B:ASN245
|
4.3
|
8.5
|
1.0
|
NE2
|
B:HIS220
|
4.3
|
6.0
|
1.0
|
OD1
|
B:ASP85
|
4.3
|
6.8
|
1.0
|
ND1
|
B:HIS38
|
4.3
|
7.2
|
1.0
|
CG
|
B:HIS38
|
4.3
|
8.1
|
1.0
|
CA
|
B:ASP36
|
4.5
|
8.4
|
1.0
|
O4
|
B:PO4604
|
4.5
|
10.2
|
1.0
|
O
|
B:HIS243
|
4.6
|
9.6
|
1.0
|
NE2
|
B:HIS118
|
4.7
|
10.2
|
1.0
|
CA
|
B:HIS243
|
4.8
|
7.0
|
1.0
|
CA
|
B:ASP85
|
4.9
|
7.0
|
1.0
|
|
Reference:
D.P.Heuts,
M.J.Weissenborn,
R.V.Olkhov,
A.M.Shaw,
J.Gummadova,
C.Levy,
N.S.Scrutton.
Crystal Structure of A Soluble Form of Human CD73 with Ecto-5'-Nucleotidase Activity. Chembiochem V. 13 2384 2012.
ISSN: ISSN 1439-4227
PubMed: 22997138
DOI: 10.1002/CBIC.201200426
Page generated: Sat Oct 26 23:47:17 2024
|